Literature DB >> 24662194

Nine-year follow-up of children with atopic dermatitis by general practitioners.

Laurent Misery1, Xavier Ansolabehere, Nathalie Grandfils, Victor Georgescu, Charles Taieb.   

Abstract

The frequency of associated comorbidity and the cost of treatments in patients with atopic dermatitis (AD) followed up in primary care settings are poorly known. We carried out a retrospective cohort study on a longitudinal electronic medical records database of patients consulting a panel of general practitioners in France. All subjects with AD diagnosed during the first year of life were selected and matched with infants without the disease according to sex (1,163 vs. 1,163). Subjects were followed up for 9 years. Associated diseases, drug consumptions and available medical costs were detailed. Comparisons between subjects and controls were carried out. Subjects with AD had more comorbidities than others, especially in respiratory and ophthalmic system organs. The number of prescribed treatments in the field of skin diseases as well as overall medical costs (general practitioner consultations and prescribed drugs) were higher among atopic subjects, but differences were attenuated with age.
© 2014 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662194     DOI: 10.1159/000358296

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  8 in total

1.  Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis.

Authors:  Robert Morlock; Pierre Chevalier; Laura Horne; Javier Nuevo; Chris Storgard; Lalitha Aiyer; Dionne M Hines; Xavier Ansolabehere; Fredrik Nyberg
Journal:  Rheumatol Ther       Date:  2016-05-25

2.  Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis.

Authors:  Fredrik Nyberg; Laura Horne; Robert Morlock; Javier Nuevo; Chris Storgard; Lalitha Aiyer; Dionne M Hines; Xavier Ansolabehere; Pierre Chevalier
Journal:  Adv Ther       Date:  2016-05-26       Impact factor: 3.845

Review 3.  A Systematic Scoping Literature Review of Publications Supporting Treatment Guidelines for Pediatric Atopic Dermatitis in Contrast to Clinical Practice Patterns.

Authors:  Elaine C Siegfried; Jennifer C Jaworski; Paola Mina-Osorio
Journal:  Dermatol Ther (Heidelb)       Date:  2018-06-01

4.  Increased healthcare utilisation among atopic children in a general practice database: a nested index-control study.

Authors:  David Hj Pols; Mark Mj Nielen; Arthur M Bohnen; Joke C Korevaar; Patrick Je Bindels
Journal:  BJGP Open       Date:  2018-04-07

Review 5.  Understanding economic evidence for the prevention and treatment of atopic eczema.

Authors:  T H Sach; E McManus; N J Levell
Journal:  Br J Dermatol       Date:  2019-04-11       Impact factor: 9.302

6.  Clinical and Economic Burden of Pediatric Mild-to-Moderate Atopic Dermatitis: A Population-Based Nested Case-Control Study in Sweden.

Authors:  Gustaf Ortsäter; Kirk Geale; Alexander Rieem Dun; Joseph C Cappelleri; Amy Cha; William Romero; Dan Henrohn; Petra Neregard; Maureen P Neary
Journal:  Dermatol Ther (Heidelb)       Date:  2020-12-18

7.  Health service use among children with and without eczema, asthma, and hay fever.

Authors:  Lene Hammer-Helmich; Allan Linneberg; Simon Francis Thomsen; Line Tang; Charlotte Glümer
Journal:  Clin Epidemiol       Date:  2016-09-13       Impact factor: 4.790

Review 8.  Ophthalmic manifestations of atopic dermatitis.

Authors:  Marta Pietruszyńska; Anna Zawadzka-Krajewska; Patrycja Duda; Monika Rogowska; Iwona Grabska-Liberek; Marek Kulus
Journal:  Postepy Dermatol Alergol       Date:  2018-11-06       Impact factor: 1.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.